oncology

Dr. Emily Kay-Rivest has joined the JGH Department of Otolaryngology-Head and Neck Surgery as a specialist in ear and skull base surgery.

Although exercise is recognized as being good for cancer patients, hematologist Dr. Nathalie Johnson is taking a closer look at how it helps those with lymphoma.

A potential breakthrough in cancer treatment, using magnetism to guide medication-carrying bacteria into tumours, will be tested in a new JGH lab.

Dr. Robin Billick, JGH Chief of Dermatology, is being honoured by the Israel Cancer Research Fund for decades of service in diagnosing cancer and saving lives.

A pace-setting JGH clinic is providing care and support to patients with rare blood cancers, while raising awareness and promoting research.

Many Hope & Cope volunteers were troubled by not being allowed to see cancer patients in person during the pandemic, but now those ties are being re-established.

As the new Director of the Lady Davis Institute, Dr. Stephen Robbins hopes to see the LDI gain even more global prominence.

Construction is under way to install a fourth linear accelerator in Radiation Oncology, making cancer treatment faster and more accurate.

Dr. William Foulkes, an expert in cancer genetics and a senior investigator at the Lady Davis Institute, has received the 2020 Wilder Penfield Prize for his research.

A major donation has led to creation of a JGH-based consortium to improve the outcomes of lung cancer patients through customized treatments.